Management of malignant glioma: Role of surgery in relation to multimodality therapy

Journal of NeuroVirology

Volumn 4, Issue 2, 1998, Pages 227-236

  Black, Perry ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Brain tumor; Malignant glioma; Multimodality therapy; Surgical resection

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CARMUSTINE; POLYMER;

CANCER IMMUNOTHERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; DRUG DELIVERY SYSTEM; GENE THERAPY; GLIOBLASTOMA; HUMAN; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STEREOTAXIC SURGERY; TREATMENT OUTCOME;

EID: 0031961063     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289809114522     Document Type: Review

References (50)

1. Ammirati M, Vick N, Liao YL, Ciric I, Mikhael M (1987). Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 21: 201-206.
2. Beaney RP, Brooks DJ, Leenders KL, Thomas DG, Jones T, Halnan KE (1985). Blood flow and oxygen utilisation in the contralateral cerebral cortex of patients with untreated intracranial tumours as studied by positron emission tomography, with observations on the effect of decompressive surgery. J Neurol Neurosurg Psychiatr 48: 310-319.
3. Brem H (1997). Personal Communication.
4. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohr G, Muller P, Morawetz R, Schold SC, and The Polymer-Brain Tumor Study Group (1995). Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 345: 1008-1012.
5. Burger PC (1987). The anatomy of astrocytomas. Mayo Clin Proc 62: 527-529.
6. Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S, Weinstein A, Nelson JS, Tsukada Y (1983). Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer 52: 999-1007.
7. Choksey MS, Valentine A, Shawdon H, Freer CE, Lindsay KW (1989). Computed tomography in the diagnosis of malignant brain tumours: do all patients require biopsy? J Neurol Neurosurg & Psychiatr 52: 821-825.
8. Ciric I, Ammirati M, Vick N, Mikhael M (1987). Supratentorial gliomas: Surgical considerations and immediate postoperative results. Gross total resection versus partial resection. Neurosurgery 21: 21-26.
9. Coffey RJ, Lunsford LD. Taylor FH (1988). Survival after stereotactic biopsy of malignant gliomas. Neurosurgery 22: 465-473.
10. Darling JL, Lewandowicz GM, Thomas DGT (1997). Chemosensitivity testing of human malignant brain tumors. In: Advances in Neuro-Oncology II. Kornblith PL and Walker MD (eds). Futura Publishing Co. Armonk, New York, pp 413-434.
11. Dyck P, Bouzaglou A, Solti-Bohman LG, Gruskin P (1983). Computer-aided, CT-guided biopsy and brachytherapy of brain tumors. Bull Clin Neurosci 48: 122-138.
12. Fadul C, Wood J, Thaler H, Galicich J, Patterson Jr RH, Posner JB (1988). Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology 38: 1374-1379.
13. Forsting M, Albert FK, Kunze S, Adams HP, Zenner D, Sartor K (1993). Extirpation of glioblastomas: MR and CT follow-up of residual tumor and regrowth patterns. AJNR 14: 77-87.
14. Fransen P, de Tribolet N (1993). Surgery of supratentorial tumors. Current Opinion in Oncology 5: 450-457.
15. Green SB, Byar DP, Walker MD, Pistenmaa DA, Alexander Jr E, Batzdorf U, Brooks WH, Hunt WE, Mealey Jr J, Odom GL, Paoletti P, Ransohoff J 2nd, Robertson JT, Selker RG, Shapiro WR, Smith Jr KR, Wilson CB, Strike TA (1983). Comparisons of carmustine, procarbazine and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 67: 121-132.
16. Gutin PH, Leibel SA (1985). Stereotaxic interstitial irradiation of malignant brain tumors. Neural Clin 3: 883-893.
17. Halperin EC, Burger PC, Bullard DE (1988). The fallacy of the localized supratentorial malignant glioma. Int J Radiation Oncol Biol Phys 15: 505-509.
18. Harsh GR IV, Levin VA, Gutin PH, Seager M, Silver P, Wilson CB (1987). Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 21: 615-621.
19. Hochberg FH, Pruitt A (1980). Assumptions in the radiotherapy of glioblastoma. Neurology 30: 907-911.
20. Hollerhage HG, Zumkeller M, Becker M, Dietz H (1991). Influence of type and extent of surgery on early results and survival time in glioblastoma multiforme. Acta Neurochir (Wien) 113: 31-37.
21. Hoshino T (1984). A commentary on the biology and growth kinetics of low-grade and high-grade gliomas. J Neurosurg 61: 895-900.
22. Jelsma R, Bucy PC (1967). The treatment of glioblastoma multiforme of the brain. J Neurosurg 27: 388-400.
23. Jeremic B, Grujicic D, Antunovic V, Djuric L, Stojanovic M, Shibamoto Y (1994). Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach. J Neuro-Oncol 21: 177-185.
24. Kala M, Sramek V, Houdek M, Vaverka M, Zmrzlik P (1993). Treatment of glioblastoma multiforme (Czech). Casopis Lekaru Ceskych 132: 653-656.
25. Kelly PJ, Daumas-Duport C, Scheithauer BW, Kali BA, Kispert DB (1987). Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 62: 450-459.
26. Kreth FW, Warnke PC, Scheremet R, Ostertag CB (1993). Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78: 762-766.
27. Kristiansen K, Hagen S, Kollevold T, Torvik A, Holme I, Nesbakken R, Hatlevoll R, Lindgren M, Brun A, Lindgren S, Notter G, Andersen AP, Eigen K (1981). Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 47: 649-652.
28. Larner JM, Phillips CD, Dion JE, Jensen ME, Newman SA, Jane JA (1995). A phase 1-2 trial of superselective carboplatin, low-dose infusional 5-fluorouracil and concurrent radiation for high-grade gliomas. Am J Clin Oncol 18: 1-7.
29. Laws Jr ER (1995). Radical resection for the treatment of glioma. Clin Neurosurg 42: 480-487.
30. Marshall LF, Jennett B, Langfitt TW (1974). Needle biopsy for the diagnosis of malignant glioma. JAMA 228: 1417-1418.
31. Miyamoto CT, Brady LW, Rackover MA, Emrich J, Class R, Bender H, Micaily B, Steplewski Z (1996). The use of epidermal growth factor receptor-425 monoclonal antibodies radiolabeled with Iodine-125 in the adjuvant treatment of patients with high grade gliomas of the brain. In: Systemic Radiotherapy with Monoclonal Antibodies. Options and Problems. Sautter-Bihl M-L, Bihl H, Wannenmacher M (eds). Springer-Verlag, Berlin, Heidelberg pp 183-192.
32. Müller W, Äfra D, Schröder R (1977). Supratentorial recurrences of gliomas. Morphological studies in relation to time intervals with astrocytomas. Acta Neurochir (Wien) 37: 75-91.
33. Nazzaro JM, Neuwelt EA (1990). The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg 73: 331-344.
34. Nitta T, Sato K (1995). Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. Cancer 75: 2727-2731.
35. Rajan B, Pickuth D, Ashley S, Traish D, Monro P, Elyan S, Brada M (1994). The management of histologically unverified presumed cerebral gliomas with radiotherapy. Int J Radiation Oncol Biol Phys 28: 405-413.
36. Ram Z, Oldfield EH (1997). Genetic approaches for the therapy of malignant brain tumors. In: Advances in Neuro-Oncology II. Kornblith PL, Walker MD (eds). Futura Publishing Co. Armonk, New York, pp 541-551.
37. Rostomily RC, Spence AM, Duong D, McCormick K, Bland M, Berger MS (1994). Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery. Neurosurgery 35: 378-388.
38. Salcman M, Kaplan RS, Samaras GM, Ducker TB, Broadwell D (1982). Aggressive multimodality therapy based on a multicompartmental model of glioblastoma. Surgery 92: 250-259.
39. Salcman M (1985). Supratentorial gliomas: Clinical features and surgical therapy. In: Neurosurgery. Wilkins RJ, Rengarchary SS (eds). McGraw-Hill Book Co., New York, vol 1, pp 579-590.
40. Salcman M (1990). Malignant glioma management. Neurosurg Clin N Amer 1: 49-63.
41. Salcman M (1996). Supratentorial gliomas: Clinical features and surgical therapy. In: Neurosurgery Wilkins RJ and Rengachary SS (eds). Second Edition, McGraw-Hill Book Co., New York, vol 1, pp 777-788.
42. Sandeman DR, Sandeman AP, Buxton P, Hughes HH, Chadwick DW, Williams IR, Baker RD, Foy PM, Shaw DM (1990). The management of patients with an intrinsic supratentorial brain tumour. Br J Neurosurg 4: 299-312.
43. Shapiro WR (1982). Treatment of neuroectodermal brain tumors. Ann Neurol 12: 231-237.
44. Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, Isaacson S, Rotman M, Asbell SO, Nelson JS, Weinstein AS, Nelson DF (1993). Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiation Oncology Biol Phys 26: 239-244.
45. Tada M, de Tribolet N (1997). Immunobiology of malignant gliomas. In: Advances in Neuro-Oncology II. Kornblith PL, Walker MD (eds). Futura Publishing Co., Armonk, New York, pp 447-467.
46. Valtonen S, Timonen U, Toivanen P, Kalimo H, Kivipelto L, Heiskanen O, Unsgaard G, Kuurne T (1997). Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neurosurgery 41: 44-48.
47. Vecht CJ, Avezaat CJ, van Putten WL, Eijkenboom WM, Stefanko SZ (1990). The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients. J Neurol Neurosurg Psychiatr 53: 466-471.
48. Walker MD, Alexander Jr E, Hunt WE, MacCarty CS, Mahaley Jr MS, Mealey Jr J, Norrell HA, Owens G, Ransohoff J, Wilson CB, Gehan EA, Strike TA (1978). Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49: 333-343.
49. Walker MD, Green SB, Byar DP, Alexander Jr E, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley Jr MS, Mealey Jr J, Owens G, Ransohoff J 2nd, Robertson JT, Shapiro WR, Smith Jr KR, Wilson CB, Strike TA (1980). Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. New Engl J Med 303: 1323-1329.
50. Young B, Oldfield EH, Markesbery WR, Haack D, Tibbs PA, McCombs P, Chin HW, Maruyama Y, Meacham WF (1981). Reoperation for glioblastoma. J Neurosurg 55: 917-921.